Cerebral haemodynamics in patients with chronic renal failure: effects of haemodialysis

被引:30
|
作者
Skinner, H [1 ]
Mackaness, C
Bedforth, N
Mahajan, R
机构
[1] City Hosp Nottingham, Dept Anaesthesia, Nottingham, England
[2] Queens Med Ctr, Nottingham NG7 2UH, England
[3] Derbyshire Royal Infirm, Dept Anaesthesia, Derby DE1 2QY, England
关键词
brain; cerebral autoregulation; blood; cerebral blood flow; haemodialysis; complications; chronic renal failure; carbon dioxide; reactivity; monitoring transient hyperaemic response;
D O I
10.1093/bja/aei016
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background. We measured middle cerebral artery (MCA) flow velocity (FV), dynamic pressure autoregulation, and carbon dioxide reactivity (CRCO2) in patients with chronic renal failure before and after haemodialysis using transcranial Doppler ultrasonography. Methods. Twelve patients on long-term haemodialysis were recruited. MCA FV was measured continuously. The transient hyperaemic response test was used to assess cerebral autoregulation, and per cent change in FV per kPa change in end-tidal carbon dioxide was calculated to assess CRCO2. All measurements were recorded before and after haemodialysis. Results. MCA FV (mean [sd]) decreased from 57 (10) cm s(-1) before to 46 (13) cm s(-1) after haemodialysis (P<0.01). The transient hyperaemic response ratio (THRR) was (mean [sd]) 1.29 (0.13) before haemodialysis and did not change significantly following haemodialysis (1.36 [0.10]). CRCO2 was 21.7 (8.3)% kPa(-1) before haemodialysis and remained unchanged afterwards (20.9 [3.8]% kPa(-1)). Values in normal subjects for MCA FV, THRR and CRCO2 are 56 (12) cm s(-1), 1.26 (0.13) and 22 (6)% kPa(-1), respectively. Conclusions. MCA FV decreases significantly after haemodialysis. Dynamic pressure autoregulation and CRCO2 remain normal in patients with chronic renal failure, and are not altered significantly by haemodialysis.
引用
收藏
页码:203 / 205
页数:3
相关论文
共 50 条
  • [1] Effects failure on of haemodialysis and renal cerebral vascular reactivity
    Skinner, H
    Mackaness, C
    Bedfortb, N
    Mahajan, R
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 : 84 - 85
  • [2] HAEMODIALYSIS IN CHRONIC RENAL FAILURE
    SHALDON, S
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1966, S : 671 - &
  • [3] Dermatological Manifestations in Chronic Renal Failure Patients on Haemodialysis
    Mirza, Reema
    Wahid, Zarnaz
    Talat, Humera
    [J]. JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2012, 11 (01): : 24 - 28
  • [4] EEG AS A MONITOR OF CEREBRAL DISTURBANCE DURING FAST AND SLOW HAEMODIALYSIS OF PATIENTS IN CHRONIC RENAL FAILURE
    KERR, DNS
    OSSELTON, JW
    [J]. ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1967, 23 (05): : 488 - &
  • [5] Plasma Ceruloplasmin in Chronic Renal Failure Patients Undergoing Haemodialysis
    Ashok, K. J.
    Sajida, M. P.
    Joseph, S.
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2010, 4 (01) : 2058 - 2060
  • [6] Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis
    Olav Spigset
    Staffan Hägg
    Bernd Stegmayr
    Rune Dahlqvist
    [J]. European Journal of Clinical Pharmacology, 2000, 56 : 699 - 703
  • [7] Complications in Patients of Acute/Chronic Renal Failure during Haemodialysis
    Ahmad, Nazir
    Sardar, Kashif
    Humayun, Mohammad
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2015, 9 (03): : 1077 - 1079
  • [8] Ocular findings in patients with chronic renal failure undergoing haemodialysis
    Vrabec, R
    Vatavuk, Z
    Pavlovic, D
    Sesar, A
    Cala, S
    Mandic, K
    Bucan, K
    [J]. COLLEGIUM ANTROPOLOGICUM, 2005, 29 : 95 - 98
  • [9] Nail changes in chronic renal failure patients under haemodialysis
    Salem, A.
    Al Mokadem, S.
    Attwa, E.
    El Raoof, S. Abd
    Ebrahim, H. M.
    Faheem, K. T.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (11) : 1326 - 1331
  • [10] Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis
    Spigset, O
    Hägg, S
    Stegmayr, B
    Dahlqvist, R
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (9-10) : 699 - 703